📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Evaluation of Pirfenidone and Nintedanib in a Human Lung Model of Fibrogenesis. (2021)

First Author: Roach KM

Attributed to: Driving innovation in precision medicine through translational life sciences research at the University of Leicester funded by UKRI

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fphar.2021.679388

PubMed Identifier: 34712131

Publication URI: http://europepmc.org/abstract/MED/34712131

Type: Journal Article/Review

Volume: 12

Parent Publication: Frontiers in pharmacology

ISSN: 1663-9812